Literature DB >> 21908931

Conditional deletion of insulin receptor in thyrocytes does not affect thyroid structure and function.

Sangmi Ock1, Seok Hong Lee, Jihyun Ahn, Tae Jin Lee, Chung-Hyun Cho, E Dale Abel, Shioko Kimura, Jaetaek Kim.   

Abstract

Thyroid-stimulating hormone (TSH) is the primary regulator of thyroid growth and function acting via cyclic AMP signaling cascades. In cultured thyrocytes, insulin and/or insulin-like growth factor-1 (IGF-1) are required for mediating thyrocyte proliferation in concert with TSH. To determine the role of insulin signaling in thyroid, growth in vivo, mice with thyrocyte-selective ablation of the insulin receptor (IR) were generated by crossing mice homozygous for a floxed IR allele with transgenic mice in which thyrocyte-specific expression of Cre recombinase was driven by the human thyroid peroxidase (TPO) gene promoter. Immunohistochemistry and Western blot analysis confirmed near complete loss of IR expression in the thyroid of thyrocyte IR knockout mice. These mice are viable and have no obvious thyroid dysfunction and macro- and microscopic thyroid morphology was normal. Thus, insulin signaling in thyrocytes does not play an essential role in the architecture and function of the thyroid in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21908931      PMCID: PMC3471790          DOI: 10.1507/endocrj.ej11-0007

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  25 in total

Review 1.  The TSH receptor reveals itself.

Authors:  Terry Davies; Russell Marians; Rauf Latif
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

2.  Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion.

Authors:  Caterina Di Cosmo; Xiao-Hui Liao; Alexandra M Dumitrescu; Nancy J Philp; Roy E Weiss; Samuel Refetoff
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

3.  Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.

Authors:  Roberta Malaguarnera; Francesco Frasca; Aldo Garozzo; Fiorenza Gianì; Giuseppe Pandini; Veronica Vella; Riccardo Vigneri; Antonino Belfiore
Journal:  J Clin Endocrinol Metab       Date:  2010-12-01       Impact factor: 5.958

4.  Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin.

Authors:  C Riedel; O Levy; N Carrasco
Journal:  J Biol Chem       Date:  2001-04-04       Impact factor: 5.157

5.  Thyroid function and effect of aging in combined hetero/homozygous mice deficient in thyroid hormone receptors alpha and beta genes.

Authors:  R E Weiss; O Chassande; E K Koo; P E Macchia; K Cua; J Samarut; S Refetoff; S Refetoff
Journal:  J Endocrinol       Date:  2002-01       Impact factor: 4.286

6.  Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer.

Authors:  A Belfiore; G Pandini; V Vella; S Squatrito; R Vigneri
Journal:  Biochimie       Date:  1999-04       Impact factor: 4.079

7.  Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.

Authors:  M Ariga; T Nedachi; M Akahori; H Sakamoto; Y Ito; F Hakuno; S Takahashi
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

8.  Interaction of TSH, insulin and insulin-like growth factors in regulating thyroid growth and function.

Authors:  M C Eggo; L K Bachrach; G N Burrow
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

9.  Introducing the thyroid gland as another victim of the insulin resistance syndrome.

Authors:  Jorge Rezzonico; Mariana Rezzonico; Eduardo Pusiol; Fabián Pitoia; Hugo Niepomniszcze
Journal:  Thyroid       Date:  2008-04       Impact factor: 6.568

10.  Thyrocyte-specific expression of Cre recombinase in transgenic mice.

Authors:  Takashi Kusakabe; Akio Kawaguchi; Rumi Kawaguchi; Lionel Feigenbaum; Shioko Kimura
Journal:  Genesis       Date:  2004-07       Impact factor: 2.487

View more
  2 in total

1.  Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.

Authors:  Yevgeniya S Kushchayeva; Sergiy V Kushchayev; Megan Startzell; Elaine Cochran; Sungyoung Auh; Yuhai Dai; Marissa Lightbourne; Monica Skarulis; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

Review 2.  Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer.

Authors:  Yevgeniya Kushchayeva; Sergiy Kushchayev; Kirk Jensen; Rebecca J Brown
Journal:  Cancers (Basel)       Date:  2022-01-22       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.